Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: Role of βγ subunits in transducing enhanced activity of the type VI isoform

Molecular Pharmacology

Volumn 49, Issue 5, 1996, Pages 907-914

  Thomas, John M ^b   Hoffman, Brian B ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ATROPINE; CARBACHOL; CHORIONIC GONADOTROPIN; CYCLIC AMP; DOPAMINE 2 RECEPTOR STIMULATING AGENT; FORSKOLIN; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN E1; QUINPIROLE;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DEPENDENCE; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ENZYME REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ALPROSTADIL; CARBACHOL; CELLS, CULTURED; CHORIONIC GONADOTROPIN; CYCLIC AMP; DOPAMINE AGONISTS; ENZYME ACTIVATION; ERGOLINES; FORSKOLIN; HUMANS; ISOENZYMES; MUSCARINIC AGONISTS; QUINPIROLE; RECEPTORS, MUSCARINIC; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSDUCIN;

EID: 0029928241     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Thomas, J. M., and B. B. Hoffman. Adenylate cyclase supersensitivity: a general means of cellular adaptation to inhibitory agonists? Trends Pharmacol. Sci. 8:308-311 (1987).
2. Thomas, J. M., and B. B. Hoffman. Sensitization of adenylyl cyclase by prior activation of inhibitory receptors, in Regulation of Cellular Signal Transduction Pathways by Desensitization and Amplification (D. R. Sibley and M. D. Houslay, eds.). John Wiley & Sons, Chichester, 193-215 (1994)
3. Hausdorff, W. P., M. G. Caron, and R. J. Lefkowitz. Turning off the signal: desensitization of beta-adrenergic receptor function. FASEB J. 4:2881-2889 (1990).
4. Sharma, S. K., W. A. Klee, and M. Nirenberg. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. USA 72:3092-3096 (1975).
5. Traber, J., R. Gullis, and B. Hamprecht. Influence of opiates on the levels of adenosine 3′5′-cyclic monophosphate in neuroblastoma X glioma cells. Life Sci. 16:1863-1868 (1975).
6. Nestler, E. J. B. T. Hope, B. T., and K. L. Widnell. Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11:995-1006 (1993).
7. Self, D. W., and E. J. Nestler. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:463-495 (1995).
8. Taussig, R., and A. G. Gilman. Mammalian membrane-bound adenylyl cyclases. J. Biol. Chem. 270:1-4 (1995)
9. Cooper, D M. F., N. Mons, and J. W. Karpen. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature (Lond.) 374: 421-424 (1995).
10. Taussig, R., J. A. Iniguez-Lluhi, and A. G. Gilman. Inhibition of adenylyl cyclase by Giα. Science (Washington D. C.) 261:218-221 (1993).
11. Taussig, R., W.-J. Tang, J. R. Hepler, and A. G. Gilman. Distinct patterns of bi-directional regulation of mammalian adenylyl cyclases. J. Biol. Chem. 269:6093-6100 (1994).
12. Bakalyar, H. A., and R. R. Reed. Identification of a specialized adenylyl cyclase that may mediate odorant detection. Science (Washington D. C.) 250:1403-1406 (1990).
13. Tang, W.-J., J. Krupinski, and A. G. Gilman. Expression and characterization of calmodulin-activated (type I) adenylyl cyclase. J. Biol. Chem. 266:8595-8603 (1991).
14. Choi, E.-J., S. T. Wong, T. R. Hinds, and D. R. Storm. Calcium and muscarinic agonist stimulation of type I adenylyl cyclase in whole cells. J. Biol. Chem. 267:12440-12442 (1992).
15. Peralta, E. G., A. Ashkenazi, J. W. Winslow, J. Ramachandran, and D. J. Capon. Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes. Nature (Lond.) 334:434-437 (1988).
16. Yoshimura, M., and D. M. F. Cooper. Type-specific stimulation of adenylyl cyclase by protein kinase C. J. Biol. Chem. 268:4604-4607 (1993).
17. Federman, A. D., B. R. Conklin, K. A. Schrader, R. R. Reed, and H. R. Bourne. Hormonal stimulation of adenylyl cyclase through Gi-protein βγ subunits. Nature (Lond.) 356:159-161 (1992).
18. Sambrook, J. E., F. Fritsch, and T. Maniatis. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989).
19. Brooker, G., J. F. Harper, W. L. Terasaki, and R. D. Moylan. Radioimmunoassay of cyclic AMP and cyclic GMP. Adv. Cyclic Nucleotide Res. 10:1-33 (1979).
20. 2+/inositol phosphate signaling pathways. Mol. Endocrinol. 6:551-556 (1992).
21. Lustig, K. D., B. R. Conklin, P. Herzmark, R. Taussig, and H. R. Bourne. Type II adenylyl cyclase integrates coincident signals from Gs, Gi, and Gq. J. Biol. Chem. 268:13900-13905 (1993).
22. Inglese, J., L. M. Luttrell, J. A. Iniguez-Lluhi, K. Touhara, W. J. Koch, and R. J. Lefkowitz. Functionally active targeting domain of the β-adrenergic receptor kinase: an inhibitor of Gβγ-mediated stimulation of type II adenylyl cyclase. Proc. Natl. Acad. Sci. USA 91:3637-3641 (1994).
23. Birnbaumer, L. Receptor-to-effector signaling through G proteins: roles for beta gamma dimers as well as alpha subunits. Cell 71:1069-1072 (1992).
24. Boyer, J. L., A. Paterson, and T. K. Harden. G-protein-mediated regulation of phospholipase C involvement of βγ subunits. Trends Cardiovasc. Med. 4:88-95 (1995).
25. Neer, E. J. Heterotrimeric G proteins. organizers of transmembrane signals. Cell 80:249-257 (1995).
26. Tang, W.-J., and A. G. Gilman. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science (Washington D. C.) 254:1500-1503 (1991).
27. Premont, R. T., J. Chen, H.-W. Ma, M. Ponnapalli, and R. Iyengar. Two members of a widely expressed subfamily of hormone-stimulated adenylyl cyclases. Proc. Natl. Acad. Sci. USA 89:9809-9813 (1992).
28. Iyengar, R. Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. FASEB J. 7:768-775 (1993).
29. Thomas, J. M., and B. B. Hoffman. Adaptive increase in adenylyl cyclase activity in NG108-15 and S49 cells induced by chronic treatment with inhibitory drugs is not due to a decrease in cyclic AMP concentrations. Cell. Signal. 4:417-428 (1992).
30. Katada, T., A. G. Gilman, Y. Watanabe, S. Bauer, and K. H. Jakobs. Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. Eur. J. Biochem. 151:431-437 (1985).
31. Bell, J. D., and L. L. Brunton. Multiple effects of phorbol esters on hormone-sensitive adenylate cyclase activity in S49 lymphoma cells. Am. J. Physiol. 252:E783-E789 (1987).
32. Yoshimasa, T., D. R. Sibley, M. Bouvier, R. J. Lefkowitz, and M. G. Caron. Cross-talk between cellular signalling pathways suggested by phorbolester-induced adenylate cyclase phosphorylation. Nature (Lond.) 327: 67-70 (1987).
33. Johnson, R. A., and M. L. Toews. Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells. Mol. Pharmacol. 37:296-303 (1990).
34. Jacobowitz, O., J. Chen, R. T. Premont, and R. Iyengar. Stimulation of specific types of Gs-stimulated adenylyl cyclases by phorbol ester treatment. J. Biol. Chem. 268:3829-3832 (1993).
35. Choi, E.-J., S. T. Wong, A. H. Dittman, and D. R. Storm. Phorbol ester stimulation of the type I and type III adenylyl cyclases in whole cells. Biochemistry 32:1891-1894 (1993).
36. Jacobowitz, O., and R. Iyengar. Phorbolester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc. Natl. Acad. Sci. USA 91: 10630-10634 (1994).
37. Xia, Z., E.-J. Choi, F. Wang, and D. R. Storm. The type II calcium/ calmodulin-sensitive adenylyl cyclase is not specific to olfactory sensory neurons. Neurosci. Lett. 144:169-173 (1992).
38. Hellevuo, K., M. Yoshimura, M. Kao, P. L. Hoffman, D. M. F. Cooper, and B. Tabakoff. A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line. Biochem. Biophys. Res. Commun. 192:311-318 (1993).
39. Premont, R. T. Identification of adenylyl cyclases by amplification using degenerate primers. Methods Enzymol. 238:116-127 (1994).
40. Watson, P. A., J. Krupinski, A. M. Kempinski, and C. D. Frankenfield. Molecular cloning and characterization of the type VII isoform of mammalian adenylyl cyclase expressed widely in mouse tissues and in S49 mouse lymphoma cells. J. Biol. Chem. 269:28893-28898 (1994).
41. 2+-inhibitable adenylyl cyclase from NCB-20 cells. Proc. Natl. Acad. Sci. USA 89:6716-6720 (1992).
42. 2+ and Gs-coupled receptors in vivo. J. Biol. Chem. 269:25400-25405 (1994).
43. 2+ and isoproterenol. Mol. Cell. Biol. 14:8272-8281 (1994).
44. Sutkowski, E. M., W.-J. Tang, C. W. Broome, J. D. Robbins, and K. B. Seamon. Regulation of forskolin interactions with type I, II, V, and VI adenylyl cyclases by Gsa. Biochemistry 33:12852-12859 (1994).
45. Chen, J., and R. Iyengar. Inhibition of cloned adenylyl cyclases by mutant-activated Gi-α and specific suppression of type 2 adenylyl cyclase inhibition by phorbol ester treatment. J. Biol. Chem. 268:12253-12256 (1993).
46. Katsushika, S., L. Chen, J. I. Kawabe, R. Nilakantan, N. J. Halnon, C. J. Homcy, and Y. Ishikawa. Cloning and characterization of a sixth adenylyl cyclase isoform: types V and VI constitute a subgroup within the mammalian adenylyl cyclase family. Proc. Natl. Acad. Sci. USA 89:8774-8778 (1992).
47. Krupinski, J., T. C. Lehman, C. D. Frankenfield, J. C. Zwaagstra, and P. A. Watson. Molecular diversity in the adenylyl cyclase family. Evidence for eight forms of the enzyme and cloning of type VI J. Biol Chem. 267: 24858-24862 (1992).
48. 2+-inhibitable adenylyl cyclase in non-excitable cells. J. Biol. Chem. 270:1149-1155 (1995).
49. 2--sensitive adenylyl cyclases. Biochem. J. 297:437-440 (1994).
50. Dunlap, K., G. G. Holz, and S. G. Rane. G proteins as regulators of ion channel function. Trends Neurosci. 10:241-244 (1987).
51. Limbird, L. E. Receptors linked to inhibition of adenylate cyclase: additional signaling mechanisms. FASEB J. 2:2686-2695 (1988).
52. Perez-Reyes, E., W. Yuan, X. Wei, and D. M. Bers. Regulation of the cloned L-type cardiac calcium channel by cyclic-AMP-dependent protein kinase. FEBS Lett. 342:119-123 (1994).
53. Matsuoka, I., R. Maldonado, N. Defer, F. Noel, J. Hanoune, and B.-F. Roques. Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur. J. Pharmacol. 268:215-221 (1994).
54. 2+/calmodulin-stimulated activity in the hypothalamus. J. Neuroendocrinol. 6:665-671 (1994).
55. Hepler, J. R., and A. G. Gilman. G proteins. Trends Biochem. Sci. 17:383-387 (1992).
56. Milligan, G. Mechanisms of multifunctional signalling by G protein-linked receptors. Trends Pharmacol. Sci. 14:239-244 (1993).